BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 360725)

  • 1. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance].
    Boroian RG
    Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of prostacyclin, a stable analogue, 6 beta-PGI1 and 6-oxo-PGF1 alpha on canine isolated parietal cells [proceedings].
    Soll AH; Whittle BJ
    Br J Pharmacol; 1979 May; 66(1):97P-98P. PubMed ID: 378311
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of exogenous prostaglandins on the cardiovascular system].
    Alekseeva NP; Makoeva LD
    Sov Med; 1980; (2):96-101. PubMed ID: 6987749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental evaluation of a new prostacyclin analog (OP 41483) for myocardial protection].
    Matsuda H; Nomura F; Hirose H; Shirakura R; Otani M; Tamura K; Kaneko M; Sasako Y; Kawashima Y
    Kyobu Geka; 1986 Jan; 39(1):43-6. PubMed ID: 3517437
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
    Boughton-Smith NK; Vane JR; Whittle BJ
    Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular research on PGI2, 6-keto-PGF1 alpha, PGF2 alpha, and 15(S)-15-methyl-PGF2 alpha.
    Marmo E; Rossi F; Lampa E; Giordano L; Caputi AP; Vacca C; Ariello B; Rosatti F
    Adv Prostaglandin Thromboxane Res; 1980; 7():701-9. PubMed ID: 6989197
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiological and biochemical parameters of prostacyclin action on the heart and the coronary vasculature.
    Schrör K; Rösen R; Link HB; Rösen P
    Adv Prostaglandin Thromboxane Res; 1980; 7():625-30. PubMed ID: 6154408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of reactivity of the coronary vessels in relation to adrenaline under the effect of prostaglandin F1 alpha (PGF1 alpha)].
    Boroian RG
    Zh Eksp Klin Med; 1974; 14(4):23-9. PubMed ID: 4422387
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of prostaglandins E1, E2, A1, F1 alpha and F2 alpha on the resistance of coronary vessels during intracoronary administration.
    Boroyan R
    Acta Biol Med Ger; 1976; 35(8-9):1083-90. PubMed ID: 1007755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 12. Dilation of large coronary arteries in conscious dogs by prostacyclin.
    Hintze TH; Kichuk MR; Stern H; Kaley G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():341-4. PubMed ID: 3159221
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
    J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
    Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
    Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
    Stinger RB; Fitzpatrick TM; Corey EJ; Ramwell PW; Rose JC; Kot PA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):521-5. PubMed ID: 6950086
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of prostacyclin on changes in basic physiological parameters in total cerebral ischemia].
    Pluta R
    Neuropatol Pol; 1985; 23(4):475-92. PubMed ID: 3913877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of prostaglandins E, A1 and F2 alpha on local brain blood circulation in non-narcotized animals].
    Briukhovetskiĭ VI; Ismailov ShI; Muratov VK; Suchkov VV
    Farmakol Toksikol; 1980; 43(1):52-5. PubMed ID: 7379991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.